Hyperuricemia on Hypertension and Metabolic Syndrome

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the influence of hyperuricemia treatment compared with placebo on participants with high risk of hypertension and metabolic syndrome.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
• Collaborator: National Council of Science and Technology, Mexico
• Treatments: Allopurinol

Criteria

Inclusion Criteria:

• adults with blood pressure from 120/80 mmHg and less than 140/90 mmHg

• no pharmacological treatment for blood pressure control

Exclusion Criteria:

• hypertension (more than 140/90mmHg)

• Diabetes Mellitus type 1 or 2

• Chronic kidney disease (MDRD less than 60)

• Hepatic Disease

• Malignancy

• Pregnancy

• patient receiving any medication